KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Free Cash Flow (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Free Cash Flow data on record, last reported at $147.5 million in Q4 2025.

  • For Q4 2025, Free Cash Flow rose 76.15% year-over-year to $147.5 million; the TTM value through Dec 2025 reached $642.7 million, up 3.76%, while the annual FY2025 figure was $737.6 million, 47.06% up from the prior year.
  • Free Cash Flow reached $147.5 million in Q4 2025 per CRL's latest filing, down from $178.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $287.2 million in Q4 2021 and bottomed at $2.5 million in Q2 2023.
  • Average Free Cash Flow over 5 years is $130.6 million, with a median of $139.8 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: tumbled 94.25% in 2023, then skyrocketed 5078.95% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $287.2 million in 2021, then plummeted by 49.26% to $145.7 million in 2022, then fell by 2.14% to $142.6 million in 2023, then crashed by 41.28% to $83.7 million in 2024, then soared by 76.15% to $147.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $147.5 million in Q4 2025, $178.2 million in Q3 2025, and $204.6 million in Q2 2025.